Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: chronic pain

Giant Cell Arteritis Challenging to Diagnose, Manage

Sebastian Unizony, MD, and John H. Stone, MD, MPH  |  March 1, 2015

Common form of primary vasculitis difficult to identify, treat, but latest research suggests potential new therapeutic targets

Filed under:ConditionsResearch RheumVasculitis Tagged with:DiagnosisGiant Cell ArteritisResearchrheumatologyTreatmentVasculitis

Drug Interactions for Trimethoprim/ Sulfamethoxazole Come to Light

Michele B. Kaufman, PharmD, BCGP  |  February 1, 2015

Plus, updates on buprenorphine, diclofenac sodium, secukinumab and other rheumatology drug news, safety information

Filed under:AnalgesicsDrug Updates Tagged with:drugFDAinteractionKaufmanrheumatologySafety

UNC’s Thurston Arthritis Research Center in the Spotlight

Gretchen Henkel  |  February 1, 2015

Approachability, collaboration foster excellence in this basic science, clinical and epidemiological research program

Filed under:Profiles Tagged with:Henkelrheumatology

Has Technology Depersonalized the Art of Medical Teaching?

Simon M. Helfgott, MD  |  February 1, 2015

Video streaming, interactive learning, flipped classrooms, self-study replacing class lectures

Filed under:Education & TrainingOpinionRheuminationsSpeak Out Rheum Tagged with:Helfgottlecturemedical teachingTechnologyvideo streaming

Biomarkers in Rheumatoid Arthritis Remain Elusive

Kathy Holliman  |  February 1, 2015

Biomarkers to assess disease progression are in use, but none can predict which therapy will work best for each patient

Filed under:ConditionsRheumatoid Arthritis Tagged with:BiomarkersHollimanRheumatoid arthritis

The Rheumatologist as Detective

Charles Radis, DO  |  February 1, 2015

A case of difficult-to-diagnose Whipple’s disease

Filed under:Conditions Tagged with:rheumatologist

2014 ACR/ARHP Annual Meeting: Rheumatology Drug Updates, Safety News

Michele B. Kaufman, PharmD, BCGP  |  January 1, 2015

Plus, hydrocodone combination products and brodalumab

Filed under:Biologics/DMARDsConditionsDrug UpdatesGout and Crystalline ArthritisMeeting Reports Tagged with:2014 ACR/ARHP Annual MeetingbrodalumabFDAhydrocodoneKaufmanrheumatologySafety

HealthKit Wellness App Holds Promise for Medicine, Rheumatology

Thomas R. Collins  |  December 1, 2014

Apple’s mobile healthcare technology may benefit patients with rheumatic disease whose conditions require regular monitoring

Filed under:AppsResearch RheumTechnologyTechnology Tagged with:appsCollinspatient careResearchrheumatologyTechnology

Cure, Effective Treatment for Lupus Nephritis Remain Elusive Despite Advances

Elena M. Massarotti, MD, & Peter H. Schur, MD  |  December 1, 2014

Rheumatology experts review history of LN, offer explanations for roadblocks to better therapies

Filed under:ConditionsDrug UpdatesResearch RheumSystemic Lupus Erythematosus Tagged with:curedrugLupusLupus nephritisPainprednisoneResearchrheumatologistrheumatologySchurSteroidsTreatment

Cryopyrin-Associated Periodic Syndromes Affected by NLRP3 Mutation

Lara C. Pullen, PhD  |  November 7, 2014

Study links NLRP3 inflammasome with amplified, extracellular inflammatory response

Filed under:ConditionsResearch Rheum Tagged with:autoinflammatory diseaseCAPSCryopyrin-Associated Periodic SyndromesPullenrheumatology

  • « Previous Page
  • 1
  • …
  • 83
  • 84
  • 85
  • 86
  • 87
  • …
  • 105
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences